Screener
CONMED CNMD Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Comprehensive income | $24,386 | $25,835 | $39,822 | $33,336 |
| Per share data: | ||||
| Net income | ||||
| Basic | $0.77 | $0.69 | $1.22 | $0.89 |
| Diluted | 0.77 | 0.69 | 1.22 | 0.88 |
| Weighted average common shares | ||||
| Basic | 30,069 | 30,949 | 30,315 | 31,011 |
| Diluted | 30,117 | 31,054 | 30,357 | 31,142 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's shares (diluted)?
- CONMED (CNMD) reported shares (diluted) of 30.1M in Q2 2026.
- How has CONMED's shares (diluted) changed year-over-year?
- CONMED's shares (diluted) decreased by 3.0% year-over-year, from 31.1M to 30.1M.
- What is the long-term trend for CONMED's shares (diluted)?
- Over 4 years (2021 to 2025), CONMED's shares (diluted) has grown at a -0.7% compound annual growth rate (CAGR), from 128.2M to 124.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about CONMED's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude